| ||
| Agennix Announces New Data from Talactoferrin Phase II Trials in ... Agennix Announces New Data from Talactoferrin Phase II Trials in Non-Small Cell Lung Cancer and in Severe Sepsis Presented at ASCO Annual Meeting, Print ... www.agennix.com/index.php?... |
Tip: Use a minus sign (-) in front of terms in your query that you want to exclude. Learn more.
Remove this alert.
Create another alert.
Manage your alerts.
No comments:
Post a Comment